Biopharmaceutical company Lexicon Pharmaceuticals Inc. said Monday its first-quarter net loss widened on lower revenue from partnerships with N.V. Organon and Bristol-Myers Squibb Co.
View full post on All News, Video and Posts related to SECTOR: Health Care
Popular Posts:
- The Truth about Diet and Weight Loss
- Health-care reform guidelines
- Is the Affordable Care Act still Revenue Neutral if the Individual Mandate is ruled unconstitutional?
- AdCare Health Systems to Lease Five Nursing Homes in Georgia, Adding $36 Million in Annualized Revenue
- Republican Whip Eric Cantor Discusses Proposed Health Care Summit & How To Lower Health Care Costs